This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lion/PolyBioCept TIL Program

Lion Biotechnologies, Inc.

Description: Lion Biotechnologies and PolyBioCept are developing tumor-infiltrating lymphocytes (TIL) manufactured with a combination of cytokines developed by researchers at the Karolinska Institute.


Lion/PolyBioCept TIL Program News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug